Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:11 PM ET Form 4
Insider Selling Neptune Insurance Holdings Inc. NP

Neptune Insurance Holdings President & Chief Risk Officer Matthew Paul Duffy Sells $1.12M of Stock

Matthew Paul Duffy, President & Chief Risk Officer, sold 41,392 shares of Neptune Insurance Holdings Inc. at $27.15 a share, worth $1.12M in total on Oct 6, 2026. Shares held after the trade: 1,964,239 (-2.1%).

Value
$1.12M
Shares
41,392
Price
$27.15
Role
President & Chief Risk Officer
Holding change
-2.1%
Trade date
Oct 6, 2026
4:11 PM ET 8-K
M&A Deal Atkore Inc. ATKR

Atkore M&A Deal with Prysmian S.p.A.

Atkore Inc. stockholders approved the adoption of the previously announced merger agreement with Prysmian S.p.A. at a special meeting held on October 7, 2026. Approximately 81.84% of outstanding shares were represented, with the merger proposal receiving overwhelming support (over 27.6 million votes in favor). Upon completion, Atkore will become a wholly owned subsidiary of Prysmian.

Counterparty
Prysmian S.p.A.
4:11 PM ET Form 4
Insider Selling Castle Biosciences Inc CSTL

Castle Biosciences Pres. & Chief Exec. Officer Derek J. Maetzold Sells $516K of Stock

Derek J. Maetzold, Pres. & Chief Exec. Officer, sold 14,496 shares of Castle Biosciences Inc at $35.57 a share, worth $516K in total on Oct 5, 2026. Shares held after the trade: 6,832 (-28.5%).

Value
$516K
Shares
14,496
Average price
$35.57
Role
Pres. & Chief Exec. Officer
Holding change
-28.5%
Trade date
Oct 5, 2026
4:11 PM ET 8-K
Shareholder Meeting Immersion Corp IMMR

Immersion Shareholder Meeting

Immersion Corporation held its fiscal year 2026 Annual Meeting of Stockholders on October 7, 2026. Shareholders elected five directors to serve until the 2027 annual meeting, ratified BDO USA, P.C. as the independent accounting firm for fiscal 2027, and approved executive compensation in an advisory vote.

4:10 PM ET Form 4
Insider Selling Blend Labs, Inc. BLND

Blend Labs Head of Blend Nima Ghamsari Sells $24.7K of Stock

Nima Ghamsari, Head of Blend, sold 24,272 shares of Blend Labs, Inc. at $1.02 a share, worth $24.7K in total on Oct 5, 2026. Shares held after the trade: 7,803,566 (-0.3%).

Value
$24.7K
Shares
24,272
Price
$1.02
Role
Head of Blend
Holding change
-0.3%
Trade date
Oct 5, 2026
4:09 PM ET Form 4
Insider Selling Capital One Financial Corp COF

Capital One Financial General Counsel & Corp Secy Matthew W. Cooper Sells $687K of Stock

Matthew W. Cooper, General Counsel & Corp Secy, sold 3,500 shares of Capital One Financial Corp at $196.22 a share, worth $687K in total on Oct 6, 2026. Shares held after the trade: 79,694 (-4.2%).

Value
$687K
Shares
3,500
Price
$196.22
Role
General Counsel & Corp Secy
Holding change
-4.2%
Trade date
Oct 6, 2026
4:09 PM ET Form 4
Insider Selling Vaxcyte, Inc. PCVX

Vaxcyte EVP, Chief Scientific Ofc, COO Jim Wassil Sells $1.56M of Stock

Jim Wassil, EVP, Chief Scientific Ofc, COO, sold 18,000 shares of Vaxcyte, Inc. at $86.74 a share, worth $1.56M in total on Oct 5, 2026. Shares held after the trade: 145,435 (-11.0%).

Value
$1.56M
Shares
18,000
Price
$86.74
Role
EVP, Chief Scientific Ofc, COO
Holding change
-11.0%
Trade date
Oct 5, 2026
4:08 PM ET Form 4
Insider Selling Vaxcyte, Inc. PCVX

Vaxcyte SVP, Finance & CAO Elvia Cowan Sells $1.65M of Stock

Elvia Cowan, SVP, Finance & CAO, sold 19,000 shares of Vaxcyte, Inc. at $86.74 a share, worth $1.65M in total on Oct 5, 2026. Shares held after the trade: 27,860 (-40.5%).

Value
$1.65M
Shares
19,000
Price
$86.74
Role
SVP, Finance & CAO
Holding change
-40.5%
Trade date
Oct 5, 2026
4:08 PM ET Form 4
Insider Selling Finance of America Companies Inc. FOA

Finance of America Companies Chief Investment Officer Jeremy Prahm Sells $79.2K of Stock

Jeremy Prahm, Chief Investment Officer, sold 6,000 shares of Finance of America Companies Inc. at $13.20 a share, worth $79.2K in total on Oct 5, 2026. Shares held after the trade: 155,856 (-3.7%).

Value
$79.2K
Shares
6,000
Price
$13.20
Role
Chief Investment Officer
Holding change
-3.7%
Trade date
Oct 5, 2026
4:06 PM ET Form 4
Insider Selling Intapp, Inc. INTA

Intapp CEO John T. Hall Sells $110K of Stock

John T. Hall, CEO, sold 3,000 shares of Intapp, Inc. at $36.50 a share, worth $110K in total on Oct 5, 2026. Shares held after the trade: 5,814,808 (-0.1%).

Value
$110K
Shares
3,000
Price
$36.50
Role
CEO
Holding change
-0.1%
Trade date
Oct 5, 2026
4:06 PM ET Form 4
Insider Selling Progress Software Corp PRGS

Progress Software CLO Yufan Stephanie Wang Sells $46.1K of Stock

Yufan Stephanie Wang, CLO, sold 1,245 shares of Progress Software Corp at $37.00 a share, worth $46.1K in total on Oct 5, 2026. Shares held after the trade: 3,487 (-26.3%).

Value
$46.1K
Shares
1,245
Price
$37.00
Role
CLO
Holding change
-26.3%
Trade date
Oct 5, 2026
4:06 PM ET 8-K
Financial Results Resources Connection, Inc. RGP

Resources Connection Financial Results

Resources Connection, Inc. (RGP) reported first quarter fiscal 2027 revenue of $98.1 million, an 18.4% decrease on a same-day constant currency basis compared to the prior year. The company reported a net loss of $8.0 million ($0.23 per diluted share) as results were impacted by lower project volume and utilization in its Consulting segment.

Term
Q1 2027

“Our first-quarter results were within the revenue and gross margin ranges we communicated in July, with adjusted SG&A expense better than our outlook. However, our revenue and profitability remained below our potential, driven primarily by lower project volume and utilization in Consulting and ongoing caution in client decision-making.”

Roger Carlile, President and Chief Executive Officer

“We remain confident in the long-term demand for RGP’s integrated model, which combines on-demand talent, consulting, and managed services to help clients move from strategy to execution. Our focus is on translating that differentiated model into more consistent revenue growth, improved utilization, and stronger profitability.”

Roger Carlile, President and Chief Executive Officer
4:06 PM ET 8-K
Loan & Debt Riley Exploration Permian, Inc. REPX

Riley Exploration Permian $130M Debt Financing with Truist Bank

Riley Exploration Permian, Inc. borrowed $130 million under its existing credit facility with Truist Bank to voluntarily prepay in full its 10.50% Senior Unsecured Notes due 2028. The refinancing leaves the company's total debt substantially unchanged while satisfying and discharging all obligations under the previous Note Purchase Agreement.

Value
$130M
Counterparty
Truist Bank
Term
through Dec 2028
4:06 PM ET 8-K
Investor Meeting Microvision, Inc. MVIS

Microvision Investor Meeting

MicroVision held a virtual business update event to reaffirm its 2026 revenue guidance of $10 million to $15 million and project a doubling of revenue in 2027. Management outlined a 'Lidar 2.0' strategy focused on commercial execution across industrial, defense, and AI data center markets while planning a significant reduction in cash burn for 2027.

4:06 PM ET 8-K
Executive Compensation Advasa Holdings, Inc. ADBT

Advasa Holdings Executive Compensation

Advasa Holdings appointed William Witherspoon as its new Chief Financial Officer, effective October 6, 2026. Mr. Witherspoon, who previously served as an independent director, will receive an annual base salary of $200,000 and is eligible for discretionary bonuses and equity grants. He succeeds CEO Grady Ryther, who had been serving as interim CFO since August 2026.

4:06 PM ET 8-K
Reverse Stock Split Medicus Pharma Ltd. MDCX

Medicus Pharma Reverse Stock Split

Medicus Pharma Ltd. announced a fifty-to-one (1-for-50) reverse stock split of its common shares effective October 12, 2026. The consolidation is intended to increase the per-share bid price to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The split was previously authorized by shareholders at the company's annual meeting on June 3, 2026.

4:06 PM ET 8-K/A
Leadership Change Ocean Power Technologies, Inc. OPTT

Ocean Power Technologies Leadership Change

Ocean Power Technologies announced that Robert Powers departed as CFO effective September 30, 2026, and will remain through October 14, 2026, to assist with the transition. The company has appointed Victoria Hay from Flexible Consulting, LLC as interim Chief Financial Officer while conducting a search for a permanent successor. Mr. Powers will receive six months of base salary and his fiscal 2026 bonus as part of a severance agreement.

Counterparty
Flexible Consulting, LLC
4:06 PM ET 8-K
Shareholder Meeting Unusual Machines, Inc. UMAC

Unusual Machines Shareholder Meeting

Unusual Machines, Inc. held its 2026 Annual Meeting of Stockholders on October 5, 2026, where shareholders elected five directors and ratified Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. Stockholders also approved a warrant grant to the company's Chief Executive Officer and an adjournment proposal, though adjournment was not necessary as all primary proposals passed.

4:06 PM ET 8-K
Leadership Change Matternet, Inc. MTTN

Matternet Leadership Change

Matternet, Inc. entered into a separation agreement with outgoing Chief Financial Officer Jason Secore, whose employment ended on September 29, 2026. Under the agreement, Mr. Secore will receive a cash payment of $156,146 and an extension of the post-termination exercise period for his equity awards. CEO Andreas Raptopoulos is currently serving as the interim CFO while the company searches for a permanent successor.

4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CEO Emily M. Leproust Sells $910K of Stock

Emily M. Leproust, CEO, sold 4,503 shares of Twist Bioscience Corp at $200.44 to $206.84 a share (average $202.10) in 7 transactions, worth $910K in total on Oct 5, 2026. Shares held after the trade: 562,805 (-0.0%).

Value
$910K
Shares
4,503
Average price
$202.10
Role
CEO
Holding change
-0.0%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling Applied Optoelectronics, Inc. AAOI

Applied Optoelectronics *** See Remarks Shu-Hua (Joshua) Yeh Sells $720K of Stock

Shu-Hua (Joshua) Yeh, *** See Remarks, sold 6,000 shares of Applied Optoelectronics, Inc. at $120.03 a share, worth $720K in total on Oct 5, 2026. Shares held after the trade: 371,498 (-1.6%).

Value
$720K
Shares
6,000
Price
$120.03
Role
*** See Remarks
Holding change
-1.6%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Chief People Officer Manuela Valente Sells $34.5K of Stock

Manuela Valente, Chief People Officer, sold 4,240 shares of SOPHiA Genetics SA at $8.13 a share, worth $34.5K in total on Oct 5, 2026. Shares held after the trade: 206,210 (-2.0%).

Value
$34.5K
Shares
4,240
Price
$8.13
Role
Chief People Officer
Holding change
-2.0%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CLO Well Daan Van Sells $50.1K of Stock

Well Daan Van, CLO, sold 6,168 shares of SOPHiA Genetics SA at $8.12 a share, worth $50.1K in total on Oct 5, 2026. Shares held after the trade: 332,716 (-1.8%).

Value
$50.1K
Shares
6,168
Price
$8.12
Role
CLO
Holding change
-1.8%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CTO Abhimanyu Verma Sells $42.9K of Stock

Abhimanyu Verma, CTO, sold 5,284 shares of SOPHiA Genetics SA at $8.12 a share, worth $42.9K in total on Oct 5, 2026. Shares held after the trade: 166,887 (-3.1%).

Value
$42.9K
Shares
5,284
Price
$8.12
Role
CTO
Holding change
-3.1%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CMO Philippe Menu Sells $60.1K of Stock

Philippe Menu, CMO, sold 7,394 shares of SOPHiA Genetics SA at $8.13 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 200,993 (-3.5%).

Value
$60.1K
Shares
7,394
Price
$8.13
Role
CMO
Holding change
-3.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CFO George Cardoza Sells $12.9K of Stock

George Cardoza, CFO, sold 1,592 shares of SOPHiA Genetics SA at $8.10 a share, worth $12.9K in total on Oct 5, 2026. Shares held after the trade: 306,726 (-0.5%).

Value
$12.9K
Shares
1,592
Price
$8.10
Role
CFO
Holding change
-0.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $327K of Stock

Jurgi Camblong, Executive Chairman, sold 40,172 shares of SOPHiA Genetics SA at $8.13 a share, worth $327K in total on Oct 5, 2026. Shares held after the trade: 3,395,650 (-1.2%).

Value
$327K
Shares
40,172
Price
$8.13
Role
Executive Chairman
Holding change
-1.2%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CEO Ross Muken Sells $80K of Stock

Ross Muken, CEO, sold 9,838 shares of SOPHiA Genetics SA at $8.13 a share, worth $80K in total on Oct 5, 2026. Shares held after the trade: 660,391 (-1.5%).

Value
$80K
Shares
9,838
Price
$8.13
Role
CEO
Holding change
-1.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CSO Zhenyu Xu Sells $60.1K of Stock

Zhenyu Xu, CSO, sold 7,394 shares of SOPHiA Genetics SA at $8.12 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 545,493 (-1.3%).

Value
$60.1K
Shares
7,394
Price
$8.12
Role
CSO
Holding change
-1.3%
Trade date
Oct 5, 2026
4:02 PM ET Form 4
Insider Selling Artiva Biotherapeutics, Inc. ARTV

Artiva Biotherapeutics CEO Fred Aslan Sells $169K of Stock

Fred Aslan, CEO, sold 23,463 shares of Artiva Biotherapeutics, Inc. at $7.20 a share, worth $169K in total on Oct 6, 2026. Shares held after the trade: 1,519,606 (-1.5%).

Value
$169K
Shares
23,463
Price
$7.20
Role
CEO
Holding change
-1.5%
Trade date
Oct 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.